EUCTR2015-004143-39-IT
Active, not recruiting
Phase 1
A Phase 3 randomised, double-blind, controlled trial of inhaled 7% hypertonic saline versus 0.9% isotonic saline for 48 weeks in patients with Cystic Fibrosis at 3-6 years of age in parallel with the North American SHIP clinical trial - Ship-CT study
ConditionsCystic FibrosisMedDRA version: 20.0Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Cystic Fibrosis
- Sponsor
- Erasmus MC
- Enrollment
- 120
- Status
- Active, not recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of CF as evidenced by one or more clinical feature consistent with the CF phenotype or positive CF newborn screen AND one or more of the following criteria: a) A documented sweat chloride \= 60 mEq/L by quantitative pilocarpineiontophoresis (QPIT) b) A documented genotype with two disease\-causing mutations in the CFTR gene
- •Informed consent by parent or legal guardian
- •Age \= 36 months and \=72 months at Screening visit
- •Ability to comply with medication use, study visits and study procedures as judged by the site investigator
- •\*\*\*Ability to execute a technician controlled or spirometer controlled chest CT scan\*\*\*????
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 120
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
Exclusion Criteria
- •Chest CT within 8 months prior to the Screening visit
- •Acute intercurrent respiratory infection, defined as an increase in cough, wheezing, or respiratory rate with onset within 3 weeks preceding Screening or Enrolment visit
- •Acute wheezing at Screening or Enrollment visit
- •Oxygen saturation \< 95% (\<90% at centres above 4000 feet elevation) at Screening or Enrollment visit
- •Other major organ dysfunction, excluding pancreatic dysfunction
- •Physical findings that would compromise the safety of the participant or the quality of the study data as determined by site investigator
- •Investigational drug use within 30 days prior to Screening or Enrolment visit
- •Treatment with inhaled hypertonic saline at any concentration within 30 days prior to Screening or Enrolment visit
- •Start of any additional inhaled saline solution at any concentration, or other hydrating agent such as mannitol or mucolytic drug such as dornase alpha within 30 days prior or following the Screening or Enrollment visit
- •Chronic lung disease not related to CF
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Saline hypertonic in preschoolers and lung structure as measured by computed tomography.EUCTR2015-004143-39-FRErasmus MC120
Active, not recruiting
Phase 1
Saline hypertonic in preschoolers and lung structure as measured by computed tomography.EUCTR2015-004143-39-NLErasmus MC120
Active, not recruiting
Phase 1
Saline Hypertonic in Preschoolers with cystic fibrosis and lung structure asmeasured by computedtomography (CT). SHIP-CT study.Cystic fibrosisMedDRA version: 19.1Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2015-004143-39-DKErasmus MC120
Active, not recruiting
Phase 1
Saline hypertonic in preschoolers and lung structure as measured by computed tomography.Cystic FibrosisMedDRA version: 19.0Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 19.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2015-004143-39-BEErasmus MC120
Active, not recruiting
Phase 1
Saline hypertonic in preschoolers and lung structure as measured by computed tomography.EUCTR2015-004143-39-ESErasmus MC116